skip to Main Content
Lab Testing Standard Published by ASTM International Cannabis Committee


W. CONSHOHOCKEN, Pa., Sept. 12, 2019 – A new ASTM International standard will help bring consistent practices to laboratories working in the cannabis industry.  The organization’s cannabis committee (D37) developed the new standard (soon to be published as D8282).

The practice was developed by a task group which reviewed documents on existing lab test-method validation and test-method development requirements.  This included reviewing documents from the Foundation of Cannabis Unified Standards (FOCUS), the American Public Health Association (APHA), and other organizations.

ASTM International member David Vaillencourt, principal consultant and owner of The GMP Collective, says this standard “fills the current gap in the cannabis testing industry with best practice guidance on how to establish test methods that will ensure consistency of results from lab to lab.”  He adds, “To date, the lack of this foundational standard has resulted in apples-to-oranges comparison of laboratory data, leading to reduced industry and consumer confidence in test results.”

In addition, he says, this standard could be valuable for testing laboratories and regulatory bodies seeking to adopt and provide guidance to companies. “We also think that the standard will drive greater consistency of potency labeling of products that is critical to consumer health and safety.”

For more information on the cannabis committee, please watch this video.

ASTM welcomes participation in the development of its standards. Become a member at The next meeting of the cannabis committee is Feb. 2, 2020, at the Atlanta Marriott Marquis in Atlanta, Georgia, USA.

To purchase standards, contact ASTM International customer relations (tel +1.877.909.ASTM; [email protected]).

About ASTM International

Committed to serving global societal needs, ASTM International positively impacts public health and safety, consumer confidence, and overall quality of life. We integrate consensus standards – developed with our international membership of volunteer technical experts – and innovative services to improve lives… Helping our world work better.

Media Inquiries: Dan Bergels, tel +1.610.832.9602; [email protected]
Committee Contact: Robert Morgan, tel +1.610.832.9732; [email protected]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published.

Recent Stories

Mississippi’s medical marijuana industry goes into effect tomorrow

The Mississippi law that will legalize medical marijuana goes into effect tomorrow, and farmers will then be allowed to start crop production. But experts say it will take some time before patients can purchase product. This Friday, dozens of laws will go into effect, including the Mississippi Medicinal Cannabis Trade act. The bill was signed…

Safe Cannabis Tableting is Easy to Swallow

Whitepaper This compaction study examines the effects of choice in carrier materials on CBD/THC tablet compressibility, powder flow, particle size and distribution, and moisture content. Natoli Scientific studied the mechanical robustness and failure points of these solid oral dose tablets using rigorous powder micromeritics and compaction profile studies. An exact science-based approach allows manufacturers to…

Cannabis Trailer Bill Passes California Assembly 66-0, Moves to Governor’s Desk

The California Assembly Wednesday night voted 66-0 in favor of AB195, a trailer bill containing a slew of measures intended to shore up the state’s ailing cannabis industry, including freezing the state excise tax at 15 percent for 3 years, and suspending the cultivation tax beginning January 1, 2023 – with July 1, 2022 the…

Public health and safety organizations engage workgroup to develop regulatory framework for cannabis in the U.S.

PRESS RELEASE June 28, 2022 –  The Association of Food and Drug Officials (AFDO) and Foundation of Cannabis United Standards (FOCUS) have officially launched efforts to develop a Federal Regulatory Framework, or FRF, for cannabis in the U.S. “Federal involvement and regulatory oversight of the U.S. cannabis industry is imperative to the health and safety…

More Categories

Back To Top
×Close search